Additional poor prognostic features include monosomy 7 (associated with progression to more advanced MDS) [7], SETBP1 mutations, and CD7 expression of myeloid blasts (both associated with decreased overall survival) [14,15]. Here, SETBP1 is linked to myelodysplastic syndrome.